{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:15:43Z","timestamp":1777540543419,"version":"3.51.4"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:00:00Z","timestamp":1569974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:00:00Z","timestamp":1569974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neuronal ceroid lipofuscinosis (NCL) type 1 (CLN1) is a neurodegenerative storage disorder caused by mutations in the gene encoding the lysosomal enzyme palmitoyl-protein thioesterase 1 (PPT1). CLN1 patients suffer from brain atrophy, mental and motor retardation, seizures, and retinal degeneration ultimately resulting in blindness. Here, we performed an in-depth analysis of the retinal phenotype of a PPT1-deficient mouse, an animal model of this condition. Reactive astrogliosis and microgliosis were evident in mutant retinas prior to the onset of retinal cell loss. Progressive accumulation of storage material, a pronounced dysregulation of various lysosomal proteins, and accumulation of sequestosome\/p62-positive aggregates in the inner nuclear layer also preceded retinal degeneration. At advanced stages of the disease, the mutant retina was characterized by a significant loss of ganglion cells, rod and cone photoreceptor cells, and rod and cone bipolar cells. Results demonstrate that PPT1 dysfunction results in early-onset pathological alterations in the mutant retina, followed by a progressive degeneration of various retinal cell types at relatively late stages of the disease. Data will serve as a reference for future work aimed at developing therapeutic strategies for the treatment of retinal degeneration in CLN1 disease.<\/jats:p>","DOI":"10.1038\/s41598-019-50726-8","type":"journal-article","created":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T10:06:02Z","timestamp":1570010762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Mice deficient in the lysosomal enzyme palmitoyl-protein thioesterase 1 (PPT1) display a complex retinal phenotype"],"prefix":"10.1038","volume":"9","author":[{"given":"Yevgeniya","family":"Atiskova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatyana","family":"Danyukova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Hagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Storch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,2]]},"reference":[{"key":"50726_CR1","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.bbadis.2006.06.010","volume":"1762","author":"M Haltia","year":"2006","unstructured":"Haltia, M. The neuronal ceroid-lipofuscinoses: from past to present. Biochimica et biophysica acta 1762, 850\u2013856, https:\/\/doi.org\/10.1016\/j.bbadis.2006.06.010 (2006).","journal-title":"Biochimica et biophysica acta"},{"key":"50726_CR2","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.bbadis.2012.08.012","volume":"1832","author":"M Haltia","year":"2013","unstructured":"Haltia, M. & Goebel, H. H. The neuronal ceroid-lipofuscinoses: a historical introduction. Biochimica et biophysica acta 1832, 1795\u20131800, https:\/\/doi.org\/10.1016\/j.bbadis.2012.08.012 (2013).","journal-title":"Biochimica et biophysica acta"},{"key":"50726_CR3","doi-asserted-by":"crossref","unstructured":"Williams, R. E. In The Neuronal Ceroid Lipofuscinosis (Batten Disease). (eds Mole, S. E., Williams, R. E. & Goebel, H. H.) 361\u2013365 (Oxford University Press, 2011).","DOI":"10.1093\/med\/9780199590018.003.0023"},{"key":"50726_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1212\/WNL.0b013e31825f0547","volume":"79","author":"RE Williams","year":"2012","unstructured":"Williams, R. E. & Mole, S. E. New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses. Neurology 79, 183\u2013191, https:\/\/doi.org\/10.1212\/WNL.0b013e31825f0547 (2012).","journal-title":"Neurology"},{"key":"50726_CR5","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.bbadis.2013.01.019","volume":"1832","author":"K Kollmann","year":"2013","unstructured":"Kollmann, K. et al. Cell biology and function of neuronal ceroid lipofuscinosis-related proteins. Biochimica et biophysica acta 1832, 1866\u20131881, https:\/\/doi.org\/10.1016\/j.bbadis.2013.01.019 (2013).","journal-title":"Biochimica et biophysica acta"},{"key":"50726_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s40263-019-00620-8","volume":"33","author":"A Kohlsch\u00fctter","year":"2019","unstructured":"Kohlsch\u00fctter, A., Schulz, A., Bartsch, U. & Storch, S. Current and emerging treatment strategies for neuronal ceroid lipofuscinoses. CNS drugs 33, 315\u2013325, https:\/\/doi.org\/10.1007\/s40263-019-00620-8 (2019).","journal-title":"CNS drugs"},{"key":"50726_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41582-019-0138-8","volume":"15","author":"TB Johnson","year":"2019","unstructured":"Johnson, T. B. et al. Therapeutic landscape for Batten disease: current treatments and future prospects. Nature reviews. Neurology 15, 161\u2013178, https:\/\/doi.org\/10.1038\/s41582-019-0138-8 (2019).","journal-title":"Neurology"},{"key":"50726_CR8","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1016\/j.bbadis.2015.04.027","volume":"1852","author":"J Carcel-Trullols","year":"2015","unstructured":"Carcel-Trullols, J., Kovacs, A. D. & Pearce, D. A. Cell biology of the NCL proteins: What they do and don\u2019t do. Biochimica et biophysica acta 1852, 2242\u20132255, https:\/\/doi.org\/10.1016\/j.bbadis.2015.04.027 (2015).","journal-title":"Biochimica et biophysica acta"},{"key":"50726_CR9","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.bbadis.2013.04.008","volume":"1832","author":"A Schulz","year":"2013","unstructured":"Schulz, A., Kohlsch\u00fctter, A., Mink, J., Simonati, A. & Williams, R. NCL diseases - clinical perspectives. Biochimica et biophysica acta 1832, 1801\u20131806, https:\/\/doi.org\/10.1016\/j.bbadis.2013.04.008 (2013).","journal-title":"Biochimica et biophysica acta"},{"key":"50726_CR10","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.gene.2016.08.031","volume":"593","author":"DE Sleat","year":"2016","unstructured":"Sleat, D. E., Gedvilaite, E., Zhang, Y., Lobel, P. & Xing, J. Analysis of large-scale whole exome sequencing data to determine the prevalence of genetically-distinct forms of neuronal ceroid lipofuscinosis. Gene 593, 284\u2013291, https:\/\/doi.org\/10.1016\/j.gene.2016.08.031 (2016).","journal-title":"Gene"},{"key":"50726_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0022-510X(73)90075-0","volume":"18","author":"P Santavuori","year":"1973","unstructured":"Santavuori, P., Haltia, M., Rapola, J. & Raitta, C. Infantile type of so-called neuronal ceroid-lipofuscinosis. 1. A clinical study of 15 patients. J Neurol Sci 18, 257\u2013267 (1973).","journal-title":"J Neurol Sci"},{"key":"50726_CR12","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1177\/088307389501000602","volume":"10","author":"HH Goebel","year":"1995","unstructured":"Goebel, H. H. The neuronal ceroid-lipofuscinoses. Journal of child neurology 10, 424\u2013437, https:\/\/doi.org\/10.1177\/088307389501000602 (1995).","journal-title":"Journal of child neurology"},{"key":"50726_CR13","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/376584a0","volume":"376","author":"J Vesa","year":"1995","unstructured":"Vesa, J. et al. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 376, 584\u2013587, https:\/\/doi.org\/10.1038\/376584a0 (1995).","journal-title":"Nature"},{"key":"50726_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1006\/mgme.2000.3056","volume":"71","author":"S Chattopadhyay","year":"2000","unstructured":"Chattopadhyay, S. & Pearce, D. A. Neural and extraneural expression of the neuronal ceroid lipofuscinoses genes CLN1, CLN2, and CLN3: functional implications for CLN3. Molecular genetics and metabolism 71, 207\u2013211, https:\/\/doi.org\/10.1006\/mgme.2000.3056 (2000).","journal-title":"Molecular genetics and metabolism"},{"key":"50726_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ymgme.2015.11.004","volume":"117","author":"JT Dearborn","year":"2016","unstructured":"Dearborn, J. T. et al. Histochemical localization of palmitoyl protein thioesterase-1 activity. Molecular genetics and metabolism 117, 210\u2013216, https:\/\/doi.org\/10.1016\/j.ymgme.2015.11.004 (2016).","journal-title":"Molecular genetics and metabolism"},{"issue":"Pt 3b","key":"50726_CR16","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/eye.1998.148","volume":"12","author":"RG Weleber","year":"1998","unstructured":"Weleber, R. G. The dystrophic retina in multisystem disorders: the electroretinogram in neuronal ceroid lipofuscinoses. Eye 12(Pt 3b), 580\u2013590, https:\/\/doi.org\/10.1038\/eye.1998.148 (1998).","journal-title":"Eye"},{"key":"50726_CR17","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ymgme.2004.06.019","volume":"83","author":"RG Weleber","year":"2004","unstructured":"Weleber, R. G. et al. Electroretinographic and clinicopathologic correlations of retinal dysfunction in infantile neuronal ceroid lipofuscinosis (infantile Batten disease). Molecular genetics and metabolism 83, 128\u2013137, https:\/\/doi.org\/10.1016\/j.ymgme.2004.06.019 (2004).","journal-title":"Molecular genetics and metabolism"},{"key":"50726_CR18","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.bbamcr.2008.11.004","volume":"1793","author":"A Jalanko","year":"2009","unstructured":"Jalanko, A. & Braulke, T. Neuronal ceroid lipofuscinoses. Biochimica et biophysica acta 1793, 697\u2013709, https:\/\/doi.org\/10.1016\/j.bbamcr.2008.11.004 (2009).","journal-title":"Biochimica et biophysica acta"},{"key":"50726_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0387-7604(88)80075-5","volume":"10","author":"P Santavuori","year":"1988","unstructured":"Santavuori, P. Neuronal ceroid-lipofuscinoses in childhood. Brain & development 10, 80\u201383 (1988).","journal-title":"Brain & development"},{"key":"50726_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10048-005-0218-3","volume":"6","author":"SE Mole","year":"2005","unstructured":"Mole, S. E., Williams, R. E. & Goebel, H. H. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics 6, 107\u2013126, https:\/\/doi.org\/10.1007\/s10048-005-0218-3 (2005).","journal-title":"Neurogenetics"},{"key":"50726_CR21","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/B978-0-444-59565-2.00038-1","volume":"113","author":"B Chabrol","year":"2013","unstructured":"Chabrol, B., Caillaud, C. & Minassian, B. Neuronal ceroid lipofuscinoses. Handbook of clinical neurology 113, 1701\u20131706, https:\/\/doi.org\/10.1016\/B978-0-444-59565-2.00038-1 (2013).","journal-title":"Handbook of clinical neurology"},{"key":"50726_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1172\/JCI3112","volume":"102","author":"AK Das","year":"1998","unstructured":"Das, A. K. et al. Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S. The Journal of clinical investigation 102, 361\u2013370, https:\/\/doi.org\/10.1172\/JCI3112 (1998).","journal-title":"The Journal of clinical investigation"},{"key":"50726_CR23","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1468-1331.2007.01668.x","volume":"14","author":"R Kalviainen","year":"2007","unstructured":"Kalviainen, R. et al. Juvenile-onset neuronal ceroid lipofuscinosis with infantile CLN1 mutation and palmitoyl-protein thioesterase deficiency. Eur J Neurol 14, 369\u2013372, https:\/\/doi.org\/10.1111\/j.1468-1331.2007.01668.x (2007).","journal-title":"Eur J Neurol"},{"key":"50726_CR24","doi-asserted-by":"crossref","unstructured":"Mole, S. E., Mitchison, H. M. & Munroe, P. B. Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5. Human mutation 14, 199\u2013215, doi:10.1002\/(SICI)1098-1004(1999)14:3<199::AID-HUMU3>3.0.CO;2-A (1999).","DOI":"10.1002\/(SICI)1098-1004(1999)14:3<199::AID-HUMU3>3.0.CO;2-A"},{"key":"50726_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1212\/01.wnl.0000252825.85947.2f","volume":"68","author":"H Ramadan","year":"2007","unstructured":"Ramadan, H. et al. Adult neuronal ceroid lipofuscinosis caused by deficiency in palmitoyl protein thioesterase 1. Neurology 68, 387\u2013388, https:\/\/doi.org\/10.1212\/01.wnl.0000252825.85947.2f (2007).","journal-title":"Neurology"},{"key":"50726_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ana.1103","volume":"50","author":"OP van Diggelen","year":"2001","unstructured":"van Diggelen, O. P. et al. Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency: first adult-onset patients of a childhood disease. Annals of neurology 50, 269\u2013272 (2001).","journal-title":"Annals of neurology"},{"key":"50726_CR27","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1007\/s00415-002-0849-3","volume":"249","author":"R Mazzei","year":"2002","unstructured":"Mazzei, R. et al. A novel mutation in the CLN1 gene in a patient with juvenile neuronal ceroid lipofuscinosis. Journal of neurology 249, 1398\u20131400, https:\/\/doi.org\/10.1007\/s00415-002-0849-3 (2002).","journal-title":"Journal of neurology"},{"key":"50726_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/ICB.0000000000000227","volume":"10","author":"TI Metelitsina","year":"2016","unstructured":"Metelitsina, T. I., Waggoner, D. J. & Grassi, M. A. Batten disease caused by a novel mutation in the PPT1 Gene. Retin Cases Brief Rep 10, 211\u2013213, https:\/\/doi.org\/10.1097\/ICB.0000000000000227 (2016).","journal-title":"Retin Cases Brief Rep"},{"key":"50726_CR29","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1006\/mgme.1999.2829","volume":"66","author":"DG Birch","year":"1999","unstructured":"Birch, D. G. Retinal degeneration in retinitis pigmentosa and neuronal ceroid lipofuscinosis: An overview. Molecular genetics and metabolism 66, 356\u2013366, https:\/\/doi.org\/10.1006\/mgme.1999.2829 (1999).","journal-title":"Molecular genetics and metabolism"},{"key":"50726_CR30","doi-asserted-by":"publisher","first-page":"13566","DOI":"10.1073\/pnas.251485198","volume":"98","author":"P Gupta","year":"2001","unstructured":"Gupta, P. et al. Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice. Proceedings of the National Academy of Sciences of the United States of America 98, 13566\u201313571, https:\/\/doi.org\/10.1073\/pnas.251485198 (2001).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"50726_CR31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.nbd.2004.08.013","volume":"18","author":"A Jalanko","year":"2005","unstructured":"Jalanko, A. et al. Mice with Ppt1Deltaex4 mutation replicate the INCL phenotype and show an inflammation-associated loss of interneurons. Neurobiology of disease 18, 226\u2013241, https:\/\/doi.org\/10.1016\/j.nbd.2004.08.013 (2005).","journal-title":"Neurobiology of disease"},{"key":"50726_CR32","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/acn3.144","volume":"1","author":"A Bouchelion","year":"2014","unstructured":"Bouchelion, A., Zhang, Z., Li, Y., Qian, H. & Mukherjee, A. B. Mice homozygous for c.451C>T mutation in Cln1 gene recapitulate INCL phenotype. Annals of clinical and translational neurology 1, 1006\u20131023, https:\/\/doi.org\/10.1002\/acn3.144 (2014).","journal-title":"Annals of clinical and translational neurology"},{"key":"50726_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/hmg\/ddu428","volume":"24","author":"JN Miller","year":"2015","unstructured":"Miller, J. N., Kovacs, A. D. & Pearce, D. A. The novel Cln1(R151X) mouse model of infantile neuronal ceroid lipofuscinosis (INCL) for testing nonsense suppression therapy. Human molecular genetics 24, 185\u2013196, https:\/\/doi.org\/10.1093\/hmg\/ddu428 (2015).","journal-title":"Human molecular genetics"},{"key":"50726_CR34","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ymthe.2005.04.018","volume":"12","author":"M Griffey","year":"2005","unstructured":"Griffey, M., Macauley, S. L., Ogilvie, J. M. & Sands, M. S. AAV2-mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis. Molecular therapy: the journal of the American Society of Gene Therapy 12, 413\u2013421, https:\/\/doi.org\/10.1016\/j.ymthe.2005.04.018 (2005).","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"key":"50726_CR35","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/brain\/awt020","volume":"136","author":"J Groh","year":"2013","unstructured":"Groh, J. et al. Immune cells perturb axons and impair neuronal survival in a mouse model of infantile neuronal ceroid lipofuscinosis. Brain: a journal of neurology 136, 1083\u20131101, https:\/\/doi.org\/10.1093\/brain\/awt020 (2013).","journal-title":"Brain: a journal of neurology"},{"key":"50726_CR36","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/jnr.21008","volume":"84","author":"B Lei","year":"2006","unstructured":"Lei, B., Tullis, G. E., Kirk, M. D., Zhang, K. & Katz, M. L. Ocular phenotype in a mouse gene knockout model for infantile neuronal ceroid lipofuscinosis. Journal of neuroscience research 84, 1139\u20131149, https:\/\/doi.org\/10.1002\/jnr.21008 (2006).","journal-title":"Journal of neuroscience research"},{"key":"50726_CR37","doi-asserted-by":"publisher","first-page":"6952","DOI":"10.1167\/iovs.13-12945","volume":"54","author":"U Bartsch","year":"2013","unstructured":"Bartsch, U. et al. Apoptotic photoreceptor loss and altered expression of lysosomal proteins in the nclf mouse model of neuronal ceroid lipofuscinosis. Investigative ophthalmology & visual science 54, 6952\u20136959, https:\/\/doi.org\/10.1167\/iovs.13-12945 (2013).","journal-title":"Investigative ophthalmology & visual science"},{"key":"50726_CR38","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.1167\/iovs.16-20158","volume":"57","author":"W Jankowiak","year":"2016","unstructured":"Jankowiak, W. et al. Retinal degeneration in mice deficient in the lysosomal membrane protein CLN7. Investigative ophthalmology & visual science 57, 4989\u20134998, https:\/\/doi.org\/10.1167\/iovs.16-20158 (2016).","journal-title":"Investigative ophthalmology & visual science"},{"key":"50726_CR39","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1167\/iovs.15-17645","volume":"57","author":"K Kruszewski","year":"2016","unstructured":"Kruszewski, K., L\u00fcllmann-Rauch, R., Dierks, T., Bartsch, U. & Damme, M. Degeneration of photoreceptor cells in arylsulfatase G-deficient mice. Investigative ophthalmology & visual science 57, 1120\u20131131, https:\/\/doi.org\/10.1167\/iovs.15-17645 (2016).","journal-title":"Investigative ophthalmology & visual science"},{"key":"50726_CR40","doi-asserted-by":"publisher","first-page":"7029","DOI":"10.1167\/iovs.14-15266","volume":"55","author":"K Flachsbarth","year":"2014","unstructured":"Flachsbarth, K. et al. Neural stem cell-based intraocular administration of ciliary neurotrophic factor attenuates the loss of axotomized ganglion cells in adult mice. Investigative ophthalmology & visual science 55, 7029\u20137039, https:\/\/doi.org\/10.1167\/iovs.14-15266 (2014).","journal-title":"Investigative ophthalmology & visual science"},{"key":"50726_CR41","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/hmg\/ddv615","volume":"25","author":"L Brandenstein","year":"2016","unstructured":"Brandenstein, L., Schweizer, M., Sedlacik, J., Fiehler, J. & Storch, S. Lysosomal dysfunction and impaired autophagy in a novel mouse model deficient for the lysosomal membrane protein Cln7. Human molecular genetics 25, 777\u2013791, https:\/\/doi.org\/10.1093\/hmg\/ddv615 (2016).","journal-title":"Human molecular genetics"},{"key":"50726_CR42","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1016\/j.bbadis.2013.05.014","volume":"1832","author":"DN Palmer","year":"2013","unstructured":"Palmer, D. N., Barry, L. A., Tyynel\u00e4, J. & Cooper, J. D. NCL disease mechanisms. Biochimica et biophysica acta 1832, 1882\u20131893, https:\/\/doi.org\/10.1016\/j.bbadis.2013.05.014 (2013).","journal-title":"Biochimica et biophysica acta"},{"key":"50726_CR43","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1016\/j.bbadis.2015.05.007","volume":"1852","author":"J Radke","year":"2015","unstructured":"Radke, J., Stenzel, W. & Goebel, H. H. Human NCL Neuropathology. Biochimica et biophysica acta 1852, 2262\u20132266, https:\/\/doi.org\/10.1016\/j.bbadis.2015.05.007 (2015).","journal-title":"Biochimica et biophysica acta"},{"key":"50726_CR44","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.bbadis.2012.11.014","volume":"1832","author":"GW Anderson","year":"2013","unstructured":"Anderson, G. W., Goebel, H. H. & Simonati, A. Human pathology in NCL. Biochimica et biophysica acta 1832, 1807\u20131826, https:\/\/doi.org\/10.1016\/j.bbadis.2012.11.014 (2013).","journal-title":"Biochimica et biophysica acta"},{"key":"50726_CR45","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/0014-5793(93)80908-D","volume":"330","author":"J Tyynel\u00e4","year":"1993","unstructured":"Tyynel\u00e4, J., Palmer, D. N., Baumann, M. & Haltia, M. Storage of saposins A and D in infantile neuronal ceroid-lipofuscinosis. FEBS letters 330, 8\u201312 (1993).","journal-title":"FEBS letters"},{"key":"50726_CR46","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1016\/j.bbadis.2015.06.014","volume":"1852","author":"DN Palmer","year":"2015","unstructured":"Palmer, D. N. The relevance of the storage of subunit c of ATP synthase in different forms and models of Batten disease (NCLs). Biochimica et biophysica acta 1852, 2287\u20132291, https:\/\/doi.org\/10.1016\/j.bbadis.2015.06.014 (2015).","journal-title":"Biochimica et biophysica acta"},{"key":"50726_CR47","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2350\/07-03-0242.1","volume":"11","author":"N Galvin","year":"2008","unstructured":"Galvin, N. et al. A murine model of infantile neuronal ceroid lipofuscinosis-ultrastructural evaluation of storage in the central nervous system and viscera. Pediatr Dev Pathol 11, 185\u2013192, https:\/\/doi.org\/10.2350\/07-03-0242.1 (2008).","journal-title":"Pediatr Dev Pathol"},{"key":"50726_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.nbd.2005.01.025","volume":"20","author":"MJ Oswald","year":"2005","unstructured":"Oswald, M. J. et al. Glial activation spreads from specific cerebral foci and precedes neurodegeneration in presymptomatic ovine neuronal ceroid lipofuscinosis (CLN6). Neurobiology of disease 20, 49\u201363, https:\/\/doi.org\/10.1016\/j.nbd.2005.01.025 (2005).","journal-title":"Neurobiology of disease"},{"key":"50726_CR49","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.nbd.2010.11.008","volume":"41","author":"GW Kay","year":"2011","unstructured":"Kay, G. W., Jay, N. P. & Palmer, D. N. The specific loss of GnRH-positive neurons from the hypothalamus of sheep with CLN6 neuronal ceroid lipofuscinosis occurs without glial activation and has only minor effects on reproduction. Neurobiology of disease 41, 614\u2013623, https:\/\/doi.org\/10.1016\/j.nbd.2010.11.008 (2011).","journal-title":"Neurobiology of disease"},{"key":"50726_CR50","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2353\/ajpath.2010.091267","volume":"177","author":"Z Shevtsova","year":"2010","unstructured":"Shevtsova, Z. et al. CNS-expressed cathepsin D prevents lymphopenia in a murine model of congenital neuronal ceroid lipofuscinosis. The American journal of pathology 177, 271\u2013279, https:\/\/doi.org\/10.2353\/ajpath.2010.091267 (2010).","journal-title":"The American journal of pathology"},{"key":"50726_CR51","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.nbd.2006.09.001","volume":"25","author":"C Kielar","year":"2007","unstructured":"Kielar, C. et al. Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis. Neurobiology of disease 25, 150\u2013162, https:\/\/doi.org\/10.1016\/j.nbd.2006.09.001 (2007).","journal-title":"Neurobiology of disease"},{"key":"50726_CR52","doi-asserted-by":"publisher","first-page":"13077","DOI":"10.1523\/JNEUROSCI.2518-14.2014","volume":"34","author":"SL Macauley","year":"2014","unstructured":"Macauley, S. L. et al. An anti-neuroinflammatory that targets dysregulated glia enhances the efficacy of CNS-directed gene therapy in murine infantile neuronal ceroid lipofuscinosis. The Journal of neuroscience: the official journal of the Society for Neuroscience 34, 13077\u201313082, https:\/\/doi.org\/10.1523\/JNEUROSCI.2518-14.2014 (2014).","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"50726_CR53","doi-asserted-by":"publisher","first-page":"15575","DOI":"10.1523\/JNEUROSCI.3579-11.2011","volume":"31","author":"SL Macauley","year":"2011","unstructured":"Macauley, S. L., Pekny, M. & Sands, M. S. The role of attenuated astrocyte activation in infantile neuronal ceroid lipofuscinosis. The Journal of neuroscience: the official journal of the Society for Neuroscience 31, 15575\u201315585, https:\/\/doi.org\/10.1523\/JNEUROSCI.3579-11.2011 (2011).","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"50726_CR54","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/glia.22962","volume":"64","author":"J Groh","year":"2016","unstructured":"Groh, J. et al. Sialoadhesin promotes neuroinflammation-related disease progression in two mouse models of CLN disease. Glia 64, 792\u2013809, https:\/\/doi.org\/10.1002\/glia.22962 (2016).","journal-title":"Glia"},{"key":"50726_CR55","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.ymthe.2017.04.021","volume":"25","author":"J Groh","year":"2017","unstructured":"Groh, J., Berve, K. & Martini, R. Fingolimod and Teriflunomide Attenuate Neurodegeneration in Mouse Models of Neuronal Ceroid Lipofuscinosis. Molecular therapy: the journal of the American Society of Gene Therapy 25, 1889\u20131899, https:\/\/doi.org\/10.1016\/j.ymthe.2017.04.021 (2017).","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"issue":"9","key":"50726_CR56","doi-asserted-by":"publisher","first-page":"dmm033597","DOI":"10.1242\/dmm.033597","volume":"11","author":"Katharina Dannhausen","year":"2018","unstructured":"Dannhausen, K., M\u00f6hle, C. & Langmann, T. Immunomodulation with minocycline rescues retinal degeneration in juvenile neuronal ceroid lipofuscinosis mice highly susceptible to light damage. Disease models & mechanisms 11, https:\/\/doi.org\/10.1242\/dmm.033597 (2018).","journal-title":"Disease Models & Mechanisms"},{"key":"50726_CR57","doi-asserted-by":"publisher","first-page":"e75963","DOI":"10.1371\/journal.pone.0075963","volume":"8","author":"M Mirza","year":"2013","unstructured":"Mirza, M. et al. Progressive retinal degeneration and glial activation in the CLN6 (nclf) mouse model of neuronal ceroid lipofuscinosis: a beneficial effect of DHA and curcumin supplementation. PloS one 8, e75963, https:\/\/doi.org\/10.1371\/journal.pone.0075963 (2013).","journal-title":"PloS one"},{"key":"50726_CR58","doi-asserted-by":"publisher","first-page":"5416","DOI":"10.1093\/hmg\/ddv266","volume":"24","author":"G Chandra","year":"2015","unstructured":"Chandra, G. et al. Cln1 gene disruption in mice reveals a common pathogenic link between two of the most lethal childhood neurodegenerative lysosomal storage disorders. Human molecular genetics 24, 5416\u20135432, https:\/\/doi.org\/10.1093\/hmg\/ddv266 (2015).","journal-title":"Human molecular genetics"},{"issue":"6","key":"50726_CR59","doi-asserted-by":"publisher","first-page":"a016907","DOI":"10.1101\/cshperspect.a016907","volume":"6","author":"C. Settembre","year":"2014","unstructured":"Settembre, C. & Ballabio, A. Lysosomal adaptation: how the lysosome responds to external cues. Cold Spring Harbor perspectives in biology 6, https:\/\/doi.org\/10.1101\/cshperspect.a016907 (2014).","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"50726_CR60","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/emboj.2012.32","volume":"31","author":"C Settembre","year":"2012","unstructured":"Settembre, C. et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. The EMBO journal 31, 1095\u20131108, https:\/\/doi.org\/10.1038\/emboj.2012.32 (2012).","journal-title":"The EMBO journal"},{"key":"50726_CR61","doi-asserted-by":"publisher","first-page":"e1395504","DOI":"10.1080\/23723556.2017.1395504","volume":"5","author":"MC Nicastri","year":"2018","unstructured":"Nicastri, M. C., Rebecca, V. W., Amaravadi, R. K. & Winkler, J. D. Dimeric quinacrines as chemical tools to identify PPT1, a new regulator of autophagy in cancer cells. Mol Cell Oncol 5, e1395504, https:\/\/doi.org\/10.1080\/23723556.2017.1395504 (2018).","journal-title":"Mol Cell Oncol"},{"key":"50726_CR62","doi-asserted-by":"publisher","unstructured":"Marques, A. R. A. et al. Enzyme replacement therapy with recombinant pro-CTSD (cathepsin D) corrects defective proteolysis and autophagy in neuronal ceroid lipofuscinosis. Autophagy, https:\/\/doi.org\/10.1080\/15548627.2019.1637200 (2019).","DOI":"10.1080\/15548627.2019.1637200"},{"key":"50726_CR63","doi-asserted-by":"publisher","first-page":"8936","DOI":"10.1523\/JNEUROSCI.18-21-08936.1998","volume":"18","author":"CJ Jeon","year":"1998","unstructured":"Jeon, C. J., Strettoi, E. & Masland, R. H. The major cell populations of the mouse retina. The Journal of neuroscience: the official journal of the Society for Neuroscience 18, 8936\u20138946 (1998).","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"50726_CR64","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1093\/hmg\/ddx074","volume":"26","author":"M Segal-Salto","year":"2017","unstructured":"Segal-Salto, M. et al. Proteomics insights into infantile neuronal ceroid lipofuscinosis (CLN1) point to the involvement of cilia pathology in the disease. Human molecular genetics 26, 1678, https:\/\/doi.org\/10.1093\/hmg\/ddx074 (2017).","journal-title":"Human molecular genetics"},{"issue":"10","key":"50726_CR65","doi-asserted-by":"publisher","first-page":"a028274","DOI":"10.1101\/cshperspect.a028274","volume":"9","author":"Kinga M. Bujakowska","year":"2017","unstructured":"Bujakowska, K. M., Liu, Q. & Pierce, E. A. Photoreceptor Cilia and Retinal Ciliopathies. Cold Spring Harbor perspectives in biology 9, https:\/\/doi.org\/10.1101\/cshperspect.a028274 (2017).","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"50726_CR66","doi-asserted-by":"publisher","first-page":"R111","DOI":"10.1093\/hmg\/dds298","volume":"21","author":"A Estrada-Cuzcano","year":"2012","unstructured":"Estrada-Cuzcano, A., Roepman, R., Cremers, F. P., den Hollander, A. I. & Mans, D. A. Non-syndromic retinal ciliopathies: translating gene discovery into therapy. Human molecular genetics 21, R111\u2013124, https:\/\/doi.org\/10.1093\/hmg\/dds298 (2012).","journal-title":"Human molecular genetics"},{"key":"50726_CR67","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.preteyeres.2017.05.001","volume":"60","author":"H May-Simera","year":"2017","unstructured":"May-Simera, H., Nagel-Wolfrum, K. & Wolfrum, U. Cilia - The sensory antennae in the eye. Progress in retinal and eye research 60, 144\u2013180, https:\/\/doi.org\/10.1016\/j.preteyeres.2017.05.001 (2017).","journal-title":"Progress in retinal and eye research"},{"key":"50726_CR68","doi-asserted-by":"publisher","first-page":"e110612","DOI":"10.1371\/journal.pone.0110612","volume":"9","author":"B Mead","year":"2014","unstructured":"Mead, B. et al. Comparative evaluation of methods for estimating retinal ganglion cell loss in retinal sections and wholemounts. PloS one 9, e110612, https:\/\/doi.org\/10.1371\/journal.pone.0110612 (2014).","journal-title":"PloS one"},{"key":"50726_CR69","doi-asserted-by":"publisher","first-page":"24131","DOI":"10.1074\/jbc.M702824200","volume":"282","author":"S Pankiv","year":"2007","unstructured":"Pankiv, S. et al. p62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. The Journal of biological chemistry 282, 24131\u201324145, https:\/\/doi.org\/10.1074\/jbc.M702824200 (2007).","journal-title":"The Journal of biological chemistry"},{"key":"50726_CR70","doi-asserted-by":"publisher","first-page":"10815","DOI":"10.1523\/JNEUROSCI.0987-13.2013","volume":"33","author":"MC Micsenyi","year":"2013","unstructured":"Micsenyi, M. C., Sikora, J., Stephney, G., Dobrenis, K. & Walkley, S. U. Lysosomal membrane permeability stimulates protein aggregate formation in neurons of a lysosomal disease. The Journal of neuroscience: the official journal of the Society for Neuroscience 33, 10815\u201310827, https:\/\/doi.org\/10.1523\/JNEUROSCI.0987-13.2013 (2013).","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"50726_CR71","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/hmg\/ddu603","volume":"24","author":"B Kowalewski","year":"2015","unstructured":"Kowalewski, B. et al. Ataxia is the major neuropathological finding in arylsulfatase G-deficient mice: similarities and dissimilarities to Sanfilippo disease (mucopolysaccharidosis type III). Human molecular genetics 24, 1856\u20131868, https:\/\/doi.org\/10.1093\/hmg\/ddu603 (2015).","journal-title":"Human molecular genetics"},{"key":"50726_CR72","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/hmg\/ddm289","volume":"17","author":"C Settembre","year":"2008","unstructured":"Settembre, C. et al. A block of autophagy in lysosomal storage disorders. Human molecular genetics 17, 119\u2013129, https:\/\/doi.org\/10.1093\/hmg\/ddm289 (2008).","journal-title":"Human molecular genetics"},{"key":"50726_CR73","doi-asserted-by":"publisher","first-page":"e35493","DOI":"10.1371\/journal.pone.0035493","volume":"7","author":"M Thelen","year":"2012","unstructured":"Thelen, M. et al. Disruption of the autophagy-lysosome pathway is involved in neuropathology of the nclf mouse model of neuronal ceroid lipofuscinosis. PloS one 7, e35493, https:\/\/doi.org\/10.1371\/journal.pone.0035493 (2012).","journal-title":"PloS one"},{"key":"50726_CR74","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/S0002-9440(10)61253-9","volume":"167","author":"M Koike","year":"2005","unstructured":"Koike, M. et al. Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease). The American journal of pathology 167, 1713\u20131728, https:\/\/doi.org\/10.1016\/S0002-9440(10)61253-9 (2005).","journal-title":"The American journal of pathology"},{"key":"50726_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-014-0078-x","volume":"2","author":"Y Tanaka","year":"2014","unstructured":"Tanaka, Y., Chambers, J. K., Matsuwaki, T., Yamanouchi, K. & Nishihara, M. Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice. Acta neuropathologica communications 2, 78, https:\/\/doi.org\/10.1186\/s40478-014-0078-x (2014).","journal-title":"Acta neuropathologica communications"},{"key":"50726_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01716-1","volume":"7","author":"H Leinonen","year":"2017","unstructured":"Leinonen, H. et al. Retinal degeneration in a mouse model of CLN5 disease is associated with compromised autophagy. Scientific reports 7, 1597, https:\/\/doi.org\/10.1038\/s41598-017-01716-1 (2017).","journal-title":"Scientific reports"},{"key":"50726_CR77","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.1167\/iovs.18-24757","volume":"59","author":"P von Eisenhart-Rothe","year":"2018","unstructured":"von Eisenhart-Rothe, P. et al. Failure of autophagy-lysosomal pathways in rod photoreceptors causes the early retinal degeneration phenotype observed in Cln6\n                           nclf mice. Investigative ophthalmology & visual science 59, 5082\u20135097, https:\/\/doi.org\/10.1167\/iovs.18-24757 (2018).","journal-title":"Investigative ophthalmology & visual science"},{"key":"50726_CR78","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1167\/iovs.08-1712","volume":"49","author":"ML Katz","year":"2008","unstructured":"Katz, M. L. et al. Retinal pathology in a canine model of late infantile neuronal ceroid lipofuscinosis. Investigative ophthalmology & visual science 49, 2686\u20132695, https:\/\/doi.org\/10.1167\/iovs.08-1712 (2008).","journal-title":"Investigative ophthalmology & visual science"},{"key":"50726_CR79","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.nbd.2007.08.017","volume":"29","author":"ML Katz","year":"2008","unstructured":"Katz, M. L., Johnson, G. S., Tullis, G. E. & Lei, B. Phenotypic characterization of a mouse model of juvenile neuronal ceroid lipofuscinosis. Neurobiology of disease 29, 242\u2013253, https:\/\/doi.org\/10.1016\/j.nbd.2007.08.017 (2008).","journal-title":"Neurobiology of disease"},{"key":"50726_CR80","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1136\/bjo.2006.091637","volume":"90","author":"J Collins","year":"2006","unstructured":"Collins, J., Holder, G. E., Herbert, H. & Adams, G. G. Batten disease: features to facilitate early diagnosis. The British journal of ophthalmology 90, 1119\u20131124, https:\/\/doi.org\/10.1136\/bjo.2006.091637 (2006).","journal-title":"The British journal of ophthalmology"},{"key":"50726_CR81","doi-asserted-by":"publisher","first-page":"e38310","DOI":"10.1371\/journal.pone.0038310","volume":"7","author":"JF Staropoli","year":"2012","unstructured":"Staropoli, J. F. et al. Large-scale phenotyping of an accurate genetic mouse model of JNCL identifies novel early pathology outside the central nervous system. PloS one 7, e38310, https:\/\/doi.org\/10.1371\/journal.pone.0038310 (2012).","journal-title":"PloS one"},{"key":"50726_CR82","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/978-1-4614-3209-8_63","volume":"801","author":"C Volz","year":"2014","unstructured":"Volz, C., Mirza, M., Langmann, T. & J\u00e4gle, H. Retinal function in aging homozygous Cln3 (Deltaex7\/8) knock-in mice. Advances in experimental medicine and biology 801, 495\u2013501, https:\/\/doi.org\/10.1007\/978-1-4614-3209-8_63 (2014).","journal-title":"Advances in experimental medicine and biology"},{"key":"50726_CR83","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.ymthe.2018.02.027","volume":"26","author":"SM Kleine Holthaus","year":"2018","unstructured":"Kleine Holthaus, S. M. et al. Prevention of photoreceptor cell loss in a Cln6\n                           nclf mouse model of batten disease requires CLN6 gene transfer to bipolar cells. Molecular therapy: the journal of the American Society of Gene Therapy 26, 1343\u20131353, https:\/\/doi.org\/10.1016\/j.ymthe.2018.02.027 (2018).","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"key":"50726_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0414-2","volume":"11","author":"RD Geraets","year":"2016","unstructured":"Geraets, R. D. et al. Moving towards effective therapeutic strategies for neuronal ceroid lipofuscinosis. Orphanet journal of rare diseases 11, 40, https:\/\/doi.org\/10.1186\/s13023-016-0414-2 (2016).","journal-title":"Orphanet journal of rare diseases"},{"key":"50726_CR85","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.bbadis.2015.04.026","volume":"1852","author":"NJ Neverman","year":"2015","unstructured":"Neverman, N. J., Best, H. L., Hofmann, S. L. & Hughes, S. M. Experimental therapies in the neuronal ceroid lipofuscinoses. Biochimica et biophysica acta 1852, 2292\u20132300, https:\/\/doi.org\/10.1016\/j.bbadis.2015.04.026 (2015).","journal-title":"Biochimica et biophysica acta"},{"key":"50726_CR86","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1177\/0883073813495960","volume":"28","author":"MS Sands","year":"2013","unstructured":"Sands, M. S. Considerations for the treatment of infantile neuronal ceroid lipofuscinosis (infantile Batten disease). Journal of child neurology 28, 1151\u20131158, https:\/\/doi.org\/10.1177\/0883073813495960 (2013).","journal-title":"Journal of child neurology"},{"key":"50726_CR87","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1474-4422(18)30368-5","volume":"18","author":"SE Mole","year":"2019","unstructured":"Mole, S. E. et al. Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis. The Lancet. Neurology 18, 107\u2013116, https:\/\/doi.org\/10.1016\/S1474-4422(18)30368-5 (2019).","journal-title":"The Lancet. Neurology"},{"key":"50726_CR88","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.bbadis.2013.05.026","volume":"1832","author":"JA Hawkins-Salsbury","year":"2013","unstructured":"Hawkins-Salsbury, J. A., Cooper, J. D. & Sands, M. S. Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease). Biochimica et biophysica acta 1832, 1906\u20131909, https:\/\/doi.org\/10.1016\/j.bbadis.2013.05.026 (2013).","journal-title":"Biochimica et biophysica acta"},{"key":"50726_CR89","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","volume":"378","author":"A Schulz","year":"2018","unstructured":"Schulz, A. et al. Study of intraventricular cerliponase alfa for CLN2 disease. The New England journal of medicine 378, 1898\u20131907, https:\/\/doi.org\/10.1056\/NEJMoa1712649 (2018).","journal-title":"The New England journal of medicine"},{"key":"50726_CR90","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/jnr.23423","volume":"92","author":"ML Katz","year":"2014","unstructured":"Katz, M. L. et al. Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease). Journal of neuroscience research 92, 1591\u20131598, https:\/\/doi.org\/10.1002\/jnr.23423 (2014).","journal-title":"Journal of neuroscience research"},{"key":"50726_CR91","doi-asserted-by":"publisher","first-page":"313ra180","DOI":"10.1126\/scitranslmed.aac6191","volume":"7","author":"ML Katz","year":"2015","unstructured":"Katz, M. L. et al. AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease. Sci Transl Med 7, 313ra180, https:\/\/doi.org\/10.1126\/scitranslmed.aac6191 (2015).","journal-title":"Sci Transl Med"},{"key":"50726_CR92","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.exer.2016.03.023","volume":"146","author":"RE Whiting","year":"2016","unstructured":"Whiting, R. E. et al. Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease. Experimental eye research 146, 276\u2013282, https:\/\/doi.org\/10.1016\/j.exer.2016.03.023 (2016).","journal-title":"Experimental eye research"},{"key":"50726_CR93","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.exer.2016.09.003","volume":"152","author":"CJ Tracy","year":"2016","unstructured":"Tracy, C. J. et al. Intravitreal implantation of TPP1-transduced stem cells delays retinal degeneration in canine CLN2 neuronal ceroid lipofuscinosis. Experimental eye research 152, 77\u201387, https:\/\/doi.org\/10.1016\/j.exer.2016.09.003 (2016).","journal-title":"Experimental eye research"},{"key":"50726_CR94","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1006\/bbrc.1994.1612","volume":"200","author":"A Klein","year":"1994","unstructured":"Klein, A. et al. Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo. Biochemical and biophysical research communications 200, 1440\u20131448, https:\/\/doi.org\/10.1006\/bbrc.1994.1612 (1994).","journal-title":"Biochemical and biophysical research communications"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50726-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50726-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50726-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T14:07:11Z","timestamp":1671286031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50726-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,2]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["50726"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-50726-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,2]]},"assertion":[{"value":"11 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14185"}}